Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from CVS

1 Drug Store Stock to Buy in 2023 and 1 to Sell

The demand for drugstore products is significantly rising owing to the growing prevalence of chronic diseases, an aging population, and favorable government policies. Hence, investing in fundamentally sound drugstore stock CVS Health (CVS) could be wise. However, it might be wise to avoid Rite Aid (RAD) due to its deteriorating…

StockNews.com

Delphi murders suspect Richard Allen mouths ‘I love you’ at two women in court before losing bid to move trial

At the hearing, Judge Fran Gull will weigh arguments on four issues: a gag order, a change of venue, a discovery request from Mr Allen’s attorneys and additional funding for investigators

The Independent UK

Eli Lilly, insulin makers sued by California over prices

Eli Lilly & Co., Novo Nordisk AS and Sanofi were sued by California over insulin prices, which the state claims are inflated through unfair and deceptive practices and disproportionately affect low-income households and people of color.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

2 Growth Stocks to Buy Before They Take Off

Growth stocks may stage a recovery as interest rate hikes might slow, and the economy might achieve a soft landing. Moreover, a market rebound seems to be in the cards in 2023. Therefore, fundamentally strong growth stocks CVS Health (CVS) and General Motors (GM) could be solid buys now. Keep…

StockNews.com

CVS is exploring a $10 billion-plus acquisition of Oak Street Health

CVS Health Corp. is exploring an acquisition of Oak Street Health Inc., which runs primary care centers for Medicare recipients, according to people familiar with the matter.

Tribune News Service

Labor board to review case filed by CVS worker who said she was fired for refusing union membership

The National Labor Relations Board is scheduled to review a complaint filed by a 68-year-old part-time employee of an Evanston, Illinois, pharmacy who said she was fired for refusing to join a union.

Chicago Tribune

Ana Walshe vanished on New Years. Now her fraudster husband is facing charges. What happened?

A week after Massachusetts mother Ana Walshe vanished, her husband Brian was arrested for hindering the police investigation. Now, investigators have discovered weapons and blood in their search. Graeme Massie reports

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Evan Ramstad: UnitedHealth and CVS, the unexpected Goliath vs. Goliath battle

Twenty years ago, Apple made computers and iPods and Google had a search engine and a few extra services.

Tribune News Service

Commentary: New FDA rules on abortion pills leave too many hurdles

Recent decisions by the U.S. Food and Drug Administration and the two biggest pharmacy chains are bringing the post-Roe v. Wade landscape more clearly into focus. America is becoming a country where abortion is a crime in some states but just a normal part of health care in others.

Tribune News Service

What FDA's abortion pill changes mean

Walgreens and CVS can now sell the abortion pill — but will they?

Salon

Walgreens, CVS to seek certification for dispensing abortion pills

Once certified, the two largest national pharmacy chains will be able to prescribe mifepristone, a pill used in medication abortions.

Chicago Sun-Times

2 Growth Stocks to Buy Now for Outsized Returns in 2023

Alarmingly high inflation and the Fed’s hawkish stance have hampered investors’ sentiment. However, the stock market could see a rebound this year. Hence, quality growth stocks CVS Health (CVS) and Universal Logistics (ULH), which look poised to deliver solid returns in 2023, might be ideal buys now. Read on….

StockNews.com

The 2 Best Stocks to Buy Amid Recent Market Volatility

The stock market has been hammered by recession fears, inflationary pressure, and soaring interest rates. Markets will likely remain volatile as the odds of the economy slipping into a recession are increasing. Given the uncertain economic backdrop, it could be wise to invest in fundamentally strong stocks, Cisco Systems, Inc.…

StockNews.com

Why we (still) can't find any children's Tylenol

For months, children’s versions of Tylenol and Motrin have felt about as hard to find as a Taylor Swift concert ticket.

Axios

Get all your
news in one place.

100's of premium titles.
One news app.

Chicago Sun-Times

Supreme Court asked to stop judges from considering ‘acquitted conduct’ during sentencing

Judges sometimes add prison time for crimes defendants were accused of — even if juries found them innocent. And the Supreme Court has turned down numerous appeals asking it to declare that the Constitution forbids it.

StockNews.com

3 Growth Stocks to Buy Now for an Early Retirement

Despite the turbulence in the stock market this year, experts expect some relief for investors in 2023. Hence, fundamentally sound growth stocks CVS Health (CVS), Archer-Daniels-Midland (ADM), and Spok Holdings (SPOK), which also pay stable dividends, might help you retire early. Keep reading.

StockNews.com

3 Hyper-Growth Stocks to Buy for Big Gains

With recent economic data showing promise, the chances of a soft landing for the economy are increasing. Hence, it could be wise to invest in fundamentally sound stocks CVS Health (CVS), Ooma (OOMA), and Neurocrine Biosciences (NBIX), which possess solid growth attributes. Read on….

WEKU

CVS and Walgreens limit sales of children's meds as the 'tripledemic' drives demand

Walgreens will limit online orders of children's fever and pain medicine to six items "to help support availability and avoid excess purchases." At CVS stores, purchases will be limited to two.

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

2 Monster Growth Stocks to Buy Now

The Fed has indicated that it will keep raising interest rates through next year. However, despite the economic uncertainties, the revival of the U.S. economy in the second half of this year has made experts hopeful of a mild recession ahead. Hence, it could be wise to invest in monster-growth…

StockNews.com

3 Health Care Stocks That Could Help You Make a Fortune

Although inflation is showing signs of cooling down and the Fed indicated a slower pace of interest rate hikes, recession fears loom. Thanks to the resilient demand for its products and services, the healthcare industry is expected to survive a challenging macroeconomic environment better than many industries. Thus, it could…

StockNews.com

4 Stocks With More Room to Run in 2023

Inflation eased again in November, which could allow the Fed to slow interest-rate hikes into the following year. Overall, the odds of the economy avoiding an anticipated recession are increasing. Given this backdrop, quality stocks CVS Health (CVS), ADT (ADT), ODP Corporation (ODP), and Universal Logistics (ULH) will likely see…

Chicago Sun-Times

Walgreens, CVS agree to pay $10 billion to settle lawsuits linked to opioid sales

Most of the money is to be used to fight the overdose epidemic. The deals are among the largest of proposed and finalized settlements over the opioid crisis totaling over $50 billion.

WEKU

CVS and Walgreens agree to pay $10 billion to settle lawsuits linked to opioid sales

CVS would pay about $5 billion and Walgreens more than $5.5 billion, though neither company has admitted wrongdoing. States have until the end of the year to accept the terms of the settlement.

StockNews.com

The 4 Fastest-Growing Stocks to Purchase Right Now

Markets have been highly volatile this year due to macroeconomic and geopolitical headwinds. However, signs of slowing inflation and dovish comments from the Fed Chair have renewed investor appetite for riskier assets. Hence, it could be wise to invest in the fastest-growing stocks, CVS Health (CVS), McKesson (MCK), Celestica (CLS),…

StockNews.com

1 No-Brainer Stock to Buy When the Market Plunges

CVS Health (CVS) beat revenue and EPS estimates for the 2022 third quarter. Moreover, the stock has gained more than 10% over the past year despite the market turmoil. Also, it currently pays its shareholders a more than 2% dividend. Therefore, CVS might be an ideal buy amid challenging times.…

1 … 16 17 18 19

People

Ketanji Brown Jackson

Mangeet Kaur BounsMangeet

Sristi Suman Jayaswal

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.